Boyd P A, Chamberlain P, Hicks N R
Prenatal Diagnosis Unit, Women's Centre, Oxford Radcliffe NHS Trust, UK.
Lancet. 1998 Nov 14;352(9140):1577-81. doi: 10.1016/s0140-6736(98)03202-4.
The benefits and harm associated with prenatal diagnosis are open to debate. We give a 6-year overview of the experience of one prenatal-diagnosis unit using a defined, unselected population.
All congenital malformations suspected prenatally and all congenital malformations, including chromosome anomalies, confirmed at birth were identified from the local Congenital Malformation Register. All fetuses or infants of women booked for delivery at the Oxford Women's Centre who had an OX postcode and date of delivery between 1991 and 1996 were eligible for the study.
725 (2%) of 33,376 babies, were judged abnormal at delivery. 396 (55%) malformed fetuses and infants had been correctly identified prenatally. 174 fetuses had a suspected abnormality identified on scan and subsequently proved to be normal. 160 (92%) of these false-positive results were attributable to the reporting of so called ultrasound soft markers. Accuracy of ultrasound diagnosis was good for structural malformations. Ultrasound soft markers were responsible for a 4% increase in detection of malformations (from 51% to 55%) and a 12-fold increase in false-positive rate (one in 2332 to one in 188). 171 pregnancies (43% of prenatally diagnosed malformed babies) were terminated because of suspected abnormality. Suspicion of abnormality in these cases was first aroused after ultrasound scan in 136 (79%); chromosome analysis because of advanced maternal age, family history, or higher risk in biochemical screening test in 25 (15%); and molecular analysis of single gene defect because of family history in ten (6%). There was a 20% reduction in prevalence of conditions compatible with survival beyond the neonatal period because of termination of such pregnancies.
More than half of all malformed fetuses can be identified prenatally in routine practice, mostly following initial suspicion from ultrasound examination. Ultrasound soft markers lead to a small increase in detection of malformations but a large increase in false positives. Further research on the impact, including psychological, and value of markers is required to determine whether the benefits of reporting them exceeds the harm. Because methods and techniques continually change, ongoing surveillance of prenatal diagnostic services is vital.
产前诊断的益处和危害存在争议。我们对一个产前诊断科室在6年里针对特定的、未经筛选的人群的经验进行了概述。
从当地先天性畸形登记处识别出所有产前疑似先天性畸形以及所有出生时确诊的先天性畸形,包括染色体异常。所有在牛津妇女中心登记分娩、邮编为OX且分娩日期在1991年至1996年之间的妇女所怀胎儿或婴儿均符合研究条件。
33376名婴儿中有725名(2%)在出生时被判定异常。396名(55%)畸形胎儿和婴儿在产前得到了正确识别。174名胎儿在超声扫描时被怀疑异常,随后被证明正常。这些假阳性结果中有160名(92%)归因于所谓超声软指标的报告。超声诊断对于结构畸形的准确性良好。超声软指标使畸形检出率提高了4%(从51%提高到55%),假阳性率提高了12倍(从2332分之一提高到188分之一)。171例妊娠(占产前诊断出的畸形婴儿的43%)因怀疑异常而终止。在这些病例中,136例(79%)在超声扫描后首先引起对异常的怀疑;25例(15%)因孕妇年龄较大、家族史或生化筛查试验中风险较高而进行染色体分析;10例(6%)因家族史而进行单基因缺陷的分子分析。由于此类妊娠的终止,与新生儿期后存活相容的疾病患病率降低了20%。
在常规实践中,超过一半的畸形胎儿可在产前被识别,大多是在超声检查最初怀疑之后。超声软指标使畸形检出率略有提高,但假阳性大幅增加。需要对这些指标的影响(包括心理影响)和价值进行进一步研究,以确定报告它们的益处是否超过危害。由于方法和技术不断变化,对产前诊断服务进行持续监测至关重要。